D-Index & Metrics Best Publications
Theodore E. Warkentin

Theodore E. Warkentin

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 113 Citations 46,687 453 World Ranking 2850 National Ranking 112

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Platelet

Heparin-induced thrombocytopenia, Heparin, Internal medicine, Platelet and Anticoagulant are his primary areas of study. His studies deal with areas such as Fondaparinux, Pre- and post-test probability, Intensive care medicine, Serology and Danaparoid as well as Heparin-induced thrombocytopenia. Theodore E. Warkentin interconnects Platelet activation, Thrombosis and Immunology in the investigation of issues within Heparin.

His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Adverse drug reaction, Surgery and Cardiology. His studies in Platelet integrate themes in fields like Hematology, Fc receptor, Monoclonal antibody and Pathology. His Anticoagulant research is multidisciplinary, relying on both Anesthesia and Intensive care.

His most cited work include:

  • Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin (1950 citations)
  • Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety (1256 citations)
  • Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. (776 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Heparin-induced thrombocytopenia, Heparin, Internal medicine, Immunology and Platelet. His Heparin-induced thrombocytopenia research is multidisciplinary, incorporating perspectives in Warfarin, Fondaparinux, Pharmacology, Low molecular weight heparin and Danaparoid. His Heparin research includes themes of Platelet activation, Thrombosis, Anesthesia and Anticoagulant.

His research investigates the connection between Thrombosis and topics such as Disseminated intravascular coagulation that intersect with issues in Coagulopathy. His Internal medicine research integrates issues from Gastroenterology, Surgery and Cardiology. He combines subjects such as Molecular biology, Cardiac surgery, Biochemistry and Monoclonal antibody with his study of Platelet.

He most often published in these fields:

  • Heparin-induced thrombocytopenia (56.33%)
  • Heparin (52.18%)
  • Internal medicine (37.55%)

What were the highlights of his more recent work (between 2015-2021)?

  • Heparin-induced thrombocytopenia (56.33%)
  • Heparin (52.18%)
  • Internal medicine (37.55%)

In recent papers he was focusing on the following fields of study:

Theodore E. Warkentin mainly investigates Heparin-induced thrombocytopenia, Heparin, Internal medicine, Thrombosis and Platelet. His Heparin-induced thrombocytopenia study is concerned with the field of Immunology as a whole. His Heparin research incorporates elements of Platelet activation, Anesthesia and Immunoassay, Antibody.

Theodore E. Warkentin has included themes like Gastroenterology and Cardiology in his Internal medicine study. His Thrombosis study combines topics from a wide range of disciplines, such as Disseminated intravascular coagulation, Gangrene and Warfarin. His studies deal with areas such as Cardiac surgery and Incidence as well as Platelet.

Between 2015 and 2021, his most popular works were:

  • Effect of Short-Term vs. Long-Term Blood Storage on Mortality after Transfusion (171 citations)
  • Effect of Short-Term vs. Long-Term Blood Storage on Mortality after Transfusion (171 citations)
  • American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. (147 citations)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin

Theodore E. Warkentin;Mark N. Levine;Jack Hirsh;Peter Horsewood.
The New England Journal of Medicine (1995)

3017 Citations

Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety

Jack Hirsh;Theodore E. Warkentin;Stephen G. Shaughnessy;Sonia S. Anand.
Chest (2001)

1805 Citations

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.

Andreas Greinacher;Thomas Thiele;Theodore E. Warkentin;Karin Weisser.
The New England Journal of Medicine (2021)

1483 Citations

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.

Jack Hirsh;Theodore E. Warkentin;Robert Raschke;Christopher Granger.
Chest (1998)

1223 Citations

Temporal aspects of heparin-induced thrombocytopenia.

Theodore E. Warkentin;John G. Kelton.
The New England Journal of Medicine (2001)

1106 Citations

Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

Theodore E. Warkentin;Andreas Greinacher.
Chest (2004)

1089 Citations

Treatment and Prevention of Heparin-Induced Thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

Theodore E. Warkentin;Andreas Greinacher;Andreas Koster;A. Michael Lincoff.
Chest (2008)

1075 Citations

A 14-year study of heparin-induced thrombocytopenia

Theodore E. Warkentin;John G. Kelton;John G. Kelton.
The American Journal of Medicine (1996)

1056 Citations

Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings

G. K. Lo;D. Juhl;T. E. Warkentin;C. S. Sigouin.
Journal of Thrombosis and Haemostasis (2006)

1054 Citations

Impact of the patient population on the risk for heparin-induced thrombocytopenia

Theodore E. Warkentin;Jo-Ann I. Sheppard;Peter Horsewood;Patricia J. Simpson.
Blood (2000)

799 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Theodore E. Warkentin

Andreas Greinacher

Andreas Greinacher

Greifswald University Hospital

Publications: 142

Mark Crowther

Mark Crowther

McMaster University

Publications: 79

Richard H. Aster

Richard H. Aster

Medical College of Wisconsin

Publications: 76

Jerrold H. Levy

Jerrold H. Levy

Duke University

Publications: 67

Douglas B. Cines

Douglas B. Cines

University of Pennsylvania

Publications: 65

John G. Kelton

John G. Kelton

McMaster University

Publications: 65

Deborah J. Cook

Deborah J. Cook

McMaster University

Publications: 51

Thomas L. Ortel

Thomas L. Ortel

Duke University

Publications: 43

Mortimer Poncz

Mortimer Poncz

Children's Hospital of Philadelphia

Publications: 43

Ian A. Greer

Ian A. Greer

Queen's University Belfast

Publications: 39

Marcel Levi

Marcel Levi

University of Amsterdam

Publications: 39

Elliott M. Antman

Elliott M. Antman

Brigham and Women's Hospital

Publications: 38

Jack Hirsh

Jack Hirsh

McMaster University

Publications: 37

Anthony K.C. Chan

Anthony K.C. Chan

McMaster Children's Hospital

Publications: 36

Jeffrey S. Ginsberg

Jeffrey S. Ginsberg

McMaster University

Publications: 35

John W. Eikelboom

John W. Eikelboom

Population Health Research Institute

Publications: 34

Trending Scientists

Raphaèle Herbin

Raphaèle Herbin

Aix-Marseille University

C. Hsein Juang

C. Hsein Juang

Clemson University

Jinhua Zhan

Jinhua Zhan

Shandong University

John R. Roth

John R. Roth

University of California, Davis

Tim R. New

Tim R. New

La Trobe University

Michael S. Engel

Michael S. Engel

University of Kansas

Kristina Lindström

Kristina Lindström

University of Helsinki

Walter F. Boron

Walter F. Boron

Case Western Reserve University

Stefania Bruno

Stefania Bruno

University of Turin

Jeffrey A. Ledbetter

Jeffrey A. Ledbetter

University of Washington

Laura E. Hughes

Laura E. Hughes

University of Cambridge

W. D. Willis

W. D. Willis

The University of Texas Medical Branch at Galveston

Andrew B. Peitzman

Andrew B. Peitzman

University of Pittsburgh

William E. Gooding

William E. Gooding

University of Pittsburgh

Charles Duyckaerts

Charles Duyckaerts

Université Paris Cité

Edward Ellis

Edward Ellis

The University of Texas Health Science Center at San Antonio

Something went wrong. Please try again later.